Services
Noom App
The Noom app is the primary platform through which users engage with the company's services. Upon creating an account, users provide physical information such as weight, height, and age, along with experiential data including lifestyle habits, personal goals, and perceived obstacles.
Users log their meals and physical activity to receive feedback through algorithmically generated insights, human coaches, peer interactions, educational articles, and interactive quizzes. The app has been reviewed by media outlets, including the Chicago Tribune, USA Today, WebMD, and Good Housekeeping.
Other services
In 2024, Noom launched Noom Vibe, a mobile application that tracks healthy habits and awards points for them, termed "vibes." That same year, Noom added a 3D body scanning feature to its main app, which is intended to help users track lean muscle mass, and it began offering a compounded GLP-1 medication. This formulation includes semaglutide, the same active ingredient found in the anti-obesity medications Wegovy and Ozempic.
Research
In 2016, a study published in Scientific Reports analyzed data from approximately 36,000 users of the Noom app, of whom 78% were female and 22% male. The data were collected between October 2012 and April 2014. To be included in the analysis, users had to log their weight at least twice per month over a period of six consecutive months. The study found that 78% of participants self-reported weight loss while using the app. The median duration of weight reporting was 267 days (approximately nine months). The frequency of data logging was positively correlated with weight loss. Additionally, male users had a higher average starting BMI and reported greater average weight loss compared to female users.
Read the full text
In 2017, the Centers for Disease Control and Prevention (CDC) recognized Noom as a certified diabetes prevention program, making it the first mobile health application to receive such designation.